This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
EverQuote Set to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
EVER eyes 34% revenue growth and a 106% EPS jump in Q2, fueled by market recovery and platform-driven demand gains.
EVER Rallies 27% YTD, Trades at Premium: Should You Buy the Stock?
by Zacks Equity Research
EverQuote gains 26.9% YTD, outperforming its industry as platform expansion and acquisitions fuel strong growth.
PRU Stock Trading at a Discount to Industry at 7.47X: Time to Buy?
by Zacks Equity Research
Prudential Financial lags the market with a 10.1% drop but trades at a discount, backed by solid ROE and a global growth strategy.
Can Assurant and Plug Elevate the Pre-Owned Tech Experience?
by Zacks Equity Research
AIZ teams up with Plug to scale device protection, cut e-waste, and tap new growth in the booming pre-owned tech market.
Can Prudential's New ActiveIncome Feature Redefine Retirement Planning?
by Zacks Equity Research
PRU debuts ActiveIncome, an annuity overlay for managed accounts that offers lifetime income without sacrificing liquidity.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
EVER, MAMA, and SFM stand out in a DuPont-driven screen with strong profit margins, asset efficiency, and moderate leverage.
Here's Why Investors Should Retain Lincoln National Stock for Now
by Zacks Equity Research
LNC's strong annuity and group protection growth, plus a Bain Capital deal, support gains despite rising costs and debt.
Aon Unveils AI-Powered Broker Copilot to Modernize Insurance Placement
by Zacks Equity Research
AON launches AI-powered Broker Copilot to streamline insurance placement and sharpen broker decision-making.
EG Stock Trading at a Discount to Industry at 6.44X: Time to Hold?
by Zacks Equity Research
Everest Group is poised to gain from strong renewal retention, continued favorable rate increases and prudent capital deployment.
4 Growth Stocks From the Insurance Space to Add to Your Portfolio
by Sushmita Sarker
Given the prospects of the insurance industry, EVER, HMN, ROOT and HCI have the potential to generate better returns than other players.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
MGIC Investment Corporation (MTG) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
MGIC (MTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
by Vaishali Doshi
Add INTU, NVMI, EVER and SEZL to your watchlist as each boasts strong liquidity, growth attributes and operational efficiency.
Here's Why Investors Should Hold American International Stock for Now
by Zacks Equity Research
AIG stock is up 20% YTD, fueled by strong premium growth and capital returns, despite rising catastrophe losses.
Here's Why Investors Should Hold Onto Aon plc Stock for Now
by Zacks Equity Research
AON rides on strong revenue growth, steady earnings forecasts and rising dividends despite margin pressure and rising debt.
Wall Street Analysts See a 38.85% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for EverQuote (EVER) points to a 38.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
PRU Lags Industry, Trades at a Discount: What Should Investors Do Now?
by Zacks Equity Research
Prudential Financial gains from solid asset-based businesses, international operations and deeper reach in the pension risk transfer market.
EverQuote (EVER) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights EverQuote, Hims & Hers Health and Sprouts Farmers Market
by Zacks Equity Research
EverQuote, Hims & Hers, and Sprouts shine with standout earnings surprises and strong DuPont-driven fundamentals.
Bet on Winning DuPont Analysis & Pick 3 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? Tap EverQuote (EVER), Hims & Hers Health (HIMS) and Sprouts Farmers Market (SFM).
ROOT Moves Above 200-Day SMA: Buy, Hold or Sell the Stock?
by Tanuka De
ROOT surges past 200-day SMA as YTD gains hit 72.6%, backed by margin growth, tech focus and strong ROE despite trading at a premium.
Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns
by Vaishali Doshi
Boost returns with liquid, efficient top-ranked stocks like NEM, PGY, EVER and SEZL, each of which is backed by strong growth and financial metrics.
Primerica Shares Up Since Q1 Earnings Surpass Estimates
by Zacks Equity Research
PRI stock edges up after Q1 earnings beat estimates, with strong sales across key segments despite rising benefits and expenses.
Houlihan Lokey Shares Up Since Q4 Earnings Beat Estimates
by Zacks Equity Research
HLI shares climb 5.4% after Q4 earnings beat, driven by strong segment growth and higher revenues despite rising expenses.
eHealth Shares Down 2.4% Despite Q1 Earnings Beat, '25 View Reaffirmed
by Zacks Equity Research
EHTH continues to witness growth in Medicare submissions across the core agency and carrier-dedicated Amplify platforms.